BIMI to Hold Annual Shareholder Meeting on July 13, 2022
BIMI International Medical Inc. (NASDAQ: BIMI) will hold its annual shareholder meeting on July 13, 2022, at 11:00 a.m. in Chongqing, China. Shareholders are encouraged to vote and submit proxies ahead of the meeting. BIMI, established in 2006, is a healthcare provider operating five private hospitals in China. The company emphasizes the importance of shareholder participation and provides a proxy voting process. Important forward-looking statements include risks related to operations, profitability, and compliance with NASDAQ listing requirements, amid challenges such as COVID-19 impacts and market demand.
- None.
- Risks to achieving profitable operations.
- Uncertainties regarding continued operation as a going concern.
- Potential difficulties in meeting NASDAQ continued listing requirements.
- Market demand for products and services may be affected by economic conditions.
- Impacts from the spread of COVID-19.
NEW YORK, June 28, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, announced that it will hold its annual meeting of shareholders on July 13, 2022 at 11:00 a.m. (local time) at the offices of the Company, 9th Floor, Building 2, Chongqing Corporation Avenue, Yuzhong District, Chongqing, P. R. China. The notice of the shareholder meeting is available on the Company's website at http://usbimi.com/.
Important Information for Shareholders
Your vote is important. Whether or not shareholders plan to attend the annual meeting, BIMI urges shareholders to vote and submit their proxies in advance of the meeting by one of the methods described in the proxy materials.
About BIMI International Medical Inc.
BIMI International Medical Inc. was founded in 2006. The Company is now exclusively a healthcare products and services provider, offering a broad range of healthcare products and related services and operates five private hospitals in China. For more information, please visit www.usbimi.com.
Safe Harbor Statement
Certain matters discussed in this news release are forward-looking statements that involve a number of risks and uncertainties including, but not limited to, the Company’s ability to achieve profitable operations, its ability to continue to operate as a going concern, its ability to continue to meet NASDAQ continued listing requirements, the effects of the spread of COVID-19, the demand for the Company’s products and services in the People’s Republic of China, general economic conditions and other risk factors detailed in the Company’s annual report and other filings with the United States Securities and Exchange Commission.
IR Contact:
Dragon Gate Investment Partners LLC
Tel: +1(646)-801-2803
Email: BIMI@dgipl.com
FAQ
What is the date of BIMI's annual shareholder meeting in 2022?
Where will BIMI's annual shareholder meeting be held?
What should shareholders do before BIMI's annual meeting?
What is the primary business of BIMI International Medical Inc.?
What risks does BIMI face according to the recent press release?
